Potash Investing Nutrien Announces Mark Thompson as a Speaker at the 2025 Wolfe Research Materials of the Future Conference
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
